Evidence map›Paper›PMID 42602972›Full record

ReviewJournal of bone oncology2026

A CTC/DTC-centered temporal framework of bone metastasis: From dissemination to dormancy and reactivation.

Zijie Yuan, Hao Zhang, Jingyu Xing, Xinghao Cao, Genkun Liu, Tao Tan, Chenglong Zhao, Cheng Yang

Abstract readReview
In one paragraph

Review in Journal of bone oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zijie YuanDepartment of Orthopedic Oncology, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
Hao ZhangDepartment of Orthopedic Oncology, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
Jingyu XingDepartment of Orthopedic Oncology, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
Xinghao CaoDepartment of Orthopedic Oncology, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
Genkun LiuDepartment of Basic Medicine, Naval Medical University, Shanghai 200003, China.
Tao TanDepartment of Orthopedics, The 905th Hospital of the People's Liberation Army Navy, Naval Medical University, Shanghai 200052, China.
Chenglong ZhaoDepartment of Orthopedic Oncology, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
Cheng YangDepartment of Orthopedic Oncology, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone metastasis is a major cause of morbidity and poor survival in solid tumors, yet its progression is often recognized only after overt lesion formation. In this review, we propose a circulating tumor cell/disseminated tumor cell (CTC/DTC)-centered temporal framework that conceptualizes bone metastasis as a sequential and selection-driven process linking dissemination, bone-specific homing, DTC establishment, dormancy, and reactivation. We summarize the key cellular and molecular mechanisms governing these transitions, with particular emphasis on tumor cell plasticity, bone marrow niche interactions, and the dormancy-reactivation interface. We further discuss the translational relevance of this approach for risk stratification, minimal residual disease assessment, treatment monitoring, and emerging experimental strategies, including single-cell multi-omics, spatial omics and biomimetic bone microenvironment models. This perspective shifts the view of bone metastasis from a static, imaging-detectable lesion to a time-resolved biological process and highlights potential windows for earlier risk assessment, disease monitoring, and biology-guided intervention.

Indexed as

Bone marrow nicheBone metastasisCirculating tumor cellsDisseminated tumor cellsMetastatic dormancyMinimal residual disease

Identifiers

PMID42602972
PMCPMC13475693

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.